Latest Expert Opinions

Signal
Opinion
Expert
HOLD
HOLD
April 25, 2018

A disappointment, having fallen on a number of missteps including negative trial results and management issues. With biotechs, the odds of getting a drug out of trials into production is small. So, it's best to have a stable of drugs and some of them will go through. Doesn't know if this is at a bottom here, but it should do well long-term. Carries an attractive below-10x earnings multiple.

Show full opinionHide full opinion
Celgene Corp (CELG-Q)
April 25, 2018

A disappointment, having fallen on a number of missteps including negative trial results and management issues. With biotechs, the odds of getting a drug out of trials into production is small. So, it's best to have a stable of drugs and some of them will go through. Doesn't know if this is at a bottom here, but it should do well long-term. Carries an attractive below-10x earnings multiple.

DON'T BUY
DON'T BUY
April 25, 2018

He's been negative on this for a long time. It's a poorly run company with little credility left. Their cash flow is a mess. All their divisions are struggling. They've exited divisions that had some positive runway and went into areas that were struggling. It will continue to fall. The company may break up down the road.

Show full opinionHide full opinion
General Electric (GE-N)
April 25, 2018

He's been negative on this for a long time. It's a poorly run company with little credility left. Their cash flow is a mess. All their divisions are struggling. They've exited divisions that had some positive runway and went into areas that were struggling. It will continue to fall. The company may break up down the road.

DON'T BUY
DON'T BUY
April 25, 2018

Fantastic company. He owned it until summer 2016 based on "price exhaustion" where a company does everything you want it to, but it's grown so big that it now has risk attributes. Multiple is very high now. It risks a serious pullback.

Show full opinionHide full opinion
Boeing (BA-N)
April 25, 2018

Fantastic company. He owned it until summer 2016 based on "price exhaustion" where a company does everything you want it to, but it's grown so big that it now has risk attributes. Multiple is very high now. It risks a serious pullback.

DON'T BUY
DON'T BUY
April 25, 2018

They sold their wireline business a few years ago and bought out the minority interest of Vodafone, putting all their eggs in one basket which did not pay off. Margins on wireless aren't as rich anymore. Telecoms don't do well during rising interest rates. Look elsewhere.

Show full opinionHide full opinion

They sold their wireline business a few years ago and bought out the minority interest of Vodafone, putting all their eggs in one basket which did not pay off. Margins on wireless aren't as rich anymore. Telecoms don't do well during rising interest rates. Look elsewhere.

PAST TOP PICK
PAST TOP PICK
April 25, 2018

(A Past Top Pick on May 2, 2017, Down 26%) They've always been sensitive to rubber prices, so their margins are being squeezed. He's watching this closely. They report April 30 and look for any signs of recovery. It's on a short leash.

Show full opinionHide full opinion

(A Past Top Pick on May 2, 2017, Down 26%) They've always been sensitive to rubber prices, so their margins are being squeezed. He's watching this closely. They report April 30 and look for any signs of recovery. It's on a short leash.

DON'T BUY
DON'T BUY
April 25, 2018

They're in a tussle with Apple over licensing and face problems with their intellectural property hijacked in China. Thet're the leader in LTE chips with a 95% market share. Great, but they can't gain much more. He sold his shares in spring 2016 based on China fears. There's so much choice among tech stocks, so Qualcomm wouldn't make the grade--though it's a good company.

Show full opinionHide full opinion
Qualcomm (QCOM-Q)
April 25, 2018

They're in a tussle with Apple over licensing and face problems with their intellectural property hijacked in China. Thet're the leader in LTE chips with a 95% market share. Great, but they can't gain much more. He sold his shares in spring 2016 based on China fears. There's so much choice among tech stocks, so Qualcomm wouldn't make the grade--though it's a good company.

BUY
BUY
April 25, 2018

He sold Goldman Sachs and bought Morgan less than a year ago. Goldman had fixed-income problems whereas Morgan Stanley developed a successful wealth management business, benefitting from lots of trading volume these days.

Show full opinionHide full opinion
Morgan Stanley (MS-N)
April 25, 2018

He sold Goldman Sachs and bought Morgan less than a year ago. Goldman had fixed-income problems whereas Morgan Stanley developed a successful wealth management business, benefitting from lots of trading volume these days.